TY - JOUR
T1 - The pharmacologic treatment of short bowel syndrome
T2 - new tricks and novel agents
AU - Bechtold, Matthew L.
AU - McClave, Stephen A.
AU - Palmer, Lena B.
AU - Nguyen, Douglas L.
AU - Urben, Lindsay M.
AU - Martindale, Robert G.
AU - Hurt, Ryan T.
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Short bowel syndrome (SBS) is a manifestation of massive resection of the intestines resulting in severe fluid, electrolyte, and vitamin/mineral deficiencies. Diet and parenteral nutrition play a large role in the management of SBS; however, pharmacologic options are becoming more readily available. These pharmacologic agents focus on reducing secretions and stimulating intestinal adaptation. The choice of medication is highly dependent on the patient's symptoms, remaining anatomy, and risk versus benefit profile for each agent. This article focuses on common and novel pharmacologic medications used in SBS, including expert advice on their indications and use.
AB - Short bowel syndrome (SBS) is a manifestation of massive resection of the intestines resulting in severe fluid, electrolyte, and vitamin/mineral deficiencies. Diet and parenteral nutrition play a large role in the management of SBS; however, pharmacologic options are becoming more readily available. These pharmacologic agents focus on reducing secretions and stimulating intestinal adaptation. The choice of medication is highly dependent on the patient's symptoms, remaining anatomy, and risk versus benefit profile for each agent. This article focuses on common and novel pharmacologic medications used in SBS, including expert advice on their indications and use.
UR - http://www.scopus.com/inward/record.url?scp=84904535034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904535034&partnerID=8YFLogxK
U2 - 10.1007/s11894-014-0392-2
DO - 10.1007/s11894-014-0392-2
M3 - Review article
C2 - 25052938
SN - 1522-8037
VL - 16
JO - Current Gastroenterology Reports
JF - Current Gastroenterology Reports
IS - 7
M1 - 392
ER -